Under a contract just announced, Baxter BioPharma Solutions will perform fill & finish services for some 60 to 90 million doses of Moderna’s Covid-19 vaccine in the US...
For mRNA vaccine maker Moderna, March is gearing up to roar in like a lion, with the tailwind setting the pace for the year ahead. Reporting 2020 financial results on Feb...
The UK’s Medicines and Healthcare Products Regulatory Agency (MRHA) cleared US biotech Moderna’s mRNA-based Covid-19 vaccine for emergency use on Jan. 7, bringing the...
Moderna’s mRNA-based Covid-19 vaccine will become the second to be administered in Europe. The European Commission granted a conditional marketing authorization to the...
The US Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for US biotech Moderna’s mRNA-based Covid-19 vaccine on Dec.18, a day after the...
US pharma giant Merck has divested its direct holding in Moderna just as the US biotech is on the cusp of receiving an emergency use authorization (EUA) for its mRNA...
On Nov. 30, US biotech Moderna became the second Covid-19 vaccine maker to apply to the Food and Drug Administration to grant an Emergency Use Authorization (EUA) for its...
Results from the Phase 3 trial of US biotech Moderna’s mRNA-1273 Covid-19 vaccine candidate unveiled on Nov. 15 showed it to be 94.5% effective against the novel...
